Home Research COVID-19 Services Publications People Teaching Job Opening News Forum --> -->
Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●DMFold ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

BioLiP
Download all results in tab-seperated text for 48 receptor-ligand interactions, whose format is explained at readme.txt.
  • Hover over PDB to view the title of the structure. Click PDB to view the structure at the RCSB PDB database. Resolution -1.00 means the resolution is unavailable, e.g., for NMR structures.
  • Click Site # to view the binding site structure. Hover over Site # to view the binding residues.
  • Hover over Ligand to view the full ligand name. Click Ligand to view the 2D diagram and other detail information of the ligand.
  • Hover over EC number to view the full name of enzymatic activity.
  • Hover over GO terms to view all GO terms.
  • Hover over UniProt to view the protein name.

    • Sort results by
    << < 1 > >>
    Go to page

    # PDB
    (Resolution Å)     		Site # Ligand EC number GO terms UniProt PubMed Binding
    affinity
    1 6ua2:A (4.2) BS01 peptide 1.1.1.205 GO:0000166 ... P12268 31999252
    2 6ua2:A (4.2) BS02 GTP 1.1.1.205 GO:0000166 ... P12268 31999252
    3 6ua2:A (4.2) BS03 GTP 1.1.1.205 GO:0000166 ... P12268 31999252
    4 6ua2:A (4.2) BS04 ATP 1.1.1.205 GO:0000166 ... P12268 31999252
    5 6ua2:A (4.2) BS05 IMP 1.1.1.205 GO:0000166 ... P12268 31999252
    6 6ua2:A (4.2) BS06 NAD 1.1.1.205 GO:0000166 ... P12268 31999252
    7 6ua2:A (4.2) BS07 ATP 1.1.1.205 GO:0000166 ... P12268 31999252
    8 6ua2:B (4.2) BS01 peptide 1.1.1.205 GO:0000166 ... P12268 31999252
    9 6ua2:B (4.2) BS02 GTP 1.1.1.205 GO:0000166 ... P12268 31999252
    10 6ua2:B (4.2) BS03 GTP 1.1.1.205 GO:0000166 ... P12268 31999252
    11 6ua2:B (4.2) BS04 ATP 1.1.1.205 GO:0000166 ... P12268 31999252
    12 6ua2:B (4.2) BS05 IMP 1.1.1.205 GO:0000166 ... P12268 31999252
    13 6ua2:B (4.2) BS06 NAD 1.1.1.205 GO:0000166 ... P12268 31999252
    14 6ua2:C (4.2) BS01 peptide 1.1.1.205 GO:0000166 ... P12268 31999252
    15 6ua2:C (4.2) BS02 ATP 1.1.1.205 GO:0000166 ... P12268 31999252
    16 6ua2:C (4.2) BS03 ATP 1.1.1.205 GO:0000166 ... P12268 31999252
    17 6ua2:C (4.2) BS04 IMP 1.1.1.205 GO:0000166 ... P12268 31999252
    18 6ua2:C (4.2) BS05 NAD 1.1.1.205 GO:0000166 ... P12268 31999252
    19 6ua2:C (4.2) BS06 ATP 1.1.1.205 GO:0000166 ... P12268 31999252
    20 6ua2:D (4.2) BS01 peptide 1.1.1.205 GO:0000166 ... P12268 31999252
    21 6ua2:D (4.2) BS02 ATP 1.1.1.205 GO:0000166 ... P12268 31999252
    22 6ua2:D (4.2) BS03 IMP 1.1.1.205 GO:0000166 ... P12268 31999252
    23 6ua2:D (4.2) BS04 NAD 1.1.1.205 GO:0000166 ... P12268 31999252
    24 6ua2:D (4.2) BS05 ATP 1.1.1.205 GO:0000166 ... P12268 31999252
    25 6ua2:E (4.2) BS01 peptide 1.1.1.205 GO:0000166 ... P12268 31999252
    26 6ua2:E (4.2) BS02 ATP 1.1.1.205 GO:0000166 ... P12268 31999252
    27 6ua2:E (4.2) BS03 GTP 1.1.1.205 GO:0000166 ... P12268 31999252
    28 6ua2:E (4.2) BS04 GTP 1.1.1.205 GO:0000166 ... P12268 31999252
    29 6ua2:E (4.2) BS05 ATP 1.1.1.205 GO:0000166 ... P12268 31999252
    30 6ua2:E (4.2) BS06 IMP 1.1.1.205 GO:0000166 ... P12268 31999252
    31 6ua2:E (4.2) BS07 NAD 1.1.1.205 GO:0000166 ... P12268 31999252
    32 6ua2:F (4.2) BS01 peptide 1.1.1.205 GO:0000166 ... P12268 31999252
    33 6ua2:F (4.2) BS02 GTP 1.1.1.205 GO:0000166 ... P12268 31999252
    34 6ua2:F (4.2) BS03 GTP 1.1.1.205 GO:0000166 ... P12268 31999252
    35 6ua2:F (4.2) BS04 ATP 1.1.1.205 GO:0000166 ... P12268 31999252
    36 6ua2:F (4.2) BS05 IMP 1.1.1.205 GO:0000166 ... P12268 31999252
    37 6ua2:F (4.2) BS06 NAD 1.1.1.205 GO:0000166 ... P12268 31999252
    38 6ua2:G (4.2) BS01 peptide 1.1.1.205 GO:0000166 ... P12268 31999252
    39 6ua2:G (4.2) BS02 ATP 1.1.1.205 GO:0000166 ... P12268 31999252
    40 6ua2:G (4.2) BS03 ATP 1.1.1.205 GO:0000166 ... P12268 31999252
    41 6ua2:G (4.2) BS04 ATP 1.1.1.205 GO:0000166 ... P12268 31999252
    42 6ua2:G (4.2) BS05 IMP 1.1.1.205 GO:0000166 ... P12268 31999252
    43 6ua2:G (4.2) BS06 NAD 1.1.1.205 GO:0000166 ... P12268 31999252
    44 6ua2:H (4.2) BS01 peptide 1.1.1.205 GO:0000166 ... P12268 31999252
    45 6ua2:H (4.2) BS02 ATP 1.1.1.205 GO:0000166 ... P12268 31999252
    46 6ua2:H (4.2) BS03 ATP 1.1.1.205 GO:0000166 ... P12268 31999252
    47 6ua2:H (4.2) BS04 IMP 1.1.1.205 GO:0000166 ... P12268 31999252
    48 6ua2:H (4.2) BS05 NAD 1.1.1.205 GO:0000166 ... P12268 31999252
    Reference:
  • Chengxin Zhang, Xi Zhang, Peter L Freddolino, and Yang Zhang. BioLiP2: an updated structure database for biologically relevent ligand-protein interactions, Nucleic Acids Research, gkad630 (2023).
  • Jianyi Yang, Ambrish Roy, and Yang Zhang. BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions, Nucleic Acids Research, 41: D1096-D1103 (2013) (download the PDF file).

    • yangzhanglabumich.edu | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218